Geode Capital Management, LLC Candel Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 687,461 shares of CADL stock, worth $3.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
687,461
Previous 455,424
50.95%
Holding current value
$3.29 Million
Previous $3.95 Million
1.75%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CADL
# of Institutions
88Shares Held
15.2MCall Options Held
536KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY2.44MShares$11.7 Million0.16% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.15MShares$10.3 Million8.46% of portfolio
-
Northpond Ventures, LLC1.94MShares$9.27 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.74MShares$8.32 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA881KShares$4.22 Million0.41% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $138M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...